Latest filing published 06 Mar 2023 for Sesen Bio, Inc., €9,512. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Elly Ryu appears in our data through filings on Sesen Bio, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 1 October 2021 to 2 March 2023.
The open-market record consists of 2 sales worth €13k, with no purchase. Outside the open market, there are 2 share grants. Since January 2023: no purchases and 2 sales on the market.
Most recently, on 6 March 2023, the filings show an open-market sale worth €9,512 in Sesen Bio, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations